Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population

References

• MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. [See comment]. Brain 2000;123(Part 4):665–676.
   PubMed Web of Science ®Google Scholar
• McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984;47:530–535.
   PubMed Web of Science ®Google Scholar
• Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, Bar PR, Jennekens FG. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066–1071.
   PubMed Web of Science ®Google Scholar
• Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001;8:157–165.
   PubMed Web of Science ®Google Scholar
• Lindh J, Tondel M, Österberg A, Vrethem M. Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Peripher Nerv Syst 2005;10:31–37.
   PubMed Web of Science ®Google Scholar
• Apostolou TG, Gokal R. Neuropathy and quality of life in diabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999;19(Suppl 2):S242–S247.
   Google Scholar
• Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007;24:187–194.
   PubMed Web of Science ®Google Scholar
• Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract 2009;9:35–42.
   PubMed Web of Science ®Google Scholar
• Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007;68:1178–1182.
   PubMed Web of Science ®Google Scholar
• Padua L, Pazzaglia C, Cavallaro T, Commodari I, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali PA, Schenone A. Quality of life is not impaired in patients with hereditary neuropathy with liability to pressure palsies. Eur J Neurol 2007;14:e45–e46.
   Google Scholar
• Padua L, Cavallaro T, Pareyson D, Quattrone A, Vita G, Schenone A, the Italian CMTQSG. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci 2008;29:193–194.
   PubMed Web of Science ®Google Scholar
• Cocito D, Paolasso I, Pazzaglia C, Tavella A, Poglio F, Ciaramitaro P, Scarmozzino A, Cossa F, Bergamasco B, Padua L. Pain affects the quality of life of neuropathic patients. Neurol Sci 2006;27:155–160.
   PubMed Web of Science ®Google Scholar
• Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA. Physical training and fatigue, fitness, and quality of life in Guillain-Barre syndrome and CIDP. Neurology 2004;63:2393–2395.
   PubMed Web of Science ®Google Scholar
• Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA, Group INCaT. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002;59:84–91.
   PubMed Web of Science ®Google Scholar
• Pfeiffer G, Wicklein EM, Ratusinski T, Schmitt L, Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 2001;70:548–550.
   PubMed Web of Science ®Google Scholar
• Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J. Quality of life in patients with axonal polyneuropathy. J Neurol 2000;247:195–199.
   PubMed Web of Science ®Google Scholar
• Vinci P, Serrao M, Millul A, Deidda A, De Santis F, Capici S, Martini D, Pierelli F, Santilli V. Quality of life in patients with Charcot-Marie-Tooth disease. [See comment]. Neurology 2005;65:922–924.
   PubMed Web of Science ®Google Scholar
• Liedberg GM, Vrethem M. Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities – a descriptive study. Disabil Rehabil 2009:31:1–7.
   PubMed Web of Science ®Google Scholar
• Abresch RTC, Jensen GT, Kilmer MP, David D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care 2002;19:39–48.
   PubMedGoogle Scholar
• Erdmann P, Teunissen L, van Genderen F, Notermans N, Lindeman E, Helders P, van Meeteren N. Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol 2007:254:1204–1211.
   PubMed Web of Science ®Google Scholar
• Nordlund A, Ekberg K, Kristenson M. EQ-5D in a general population survey – a description of the most commonly reported EQ-5D health states using the SF-36. Qual Life Res 2005;14:1099–1109.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–483.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998;51:1105–1113.
   Google Scholar
• Sullivan M, Karlsson J, Ware JE Jr. Hälsoenkät: Svensk manual och tolkningsguide (Swedish Manual and Interpretation Guide). Gothenburg: Sahlgrenska University Hospital; 1994.
   Google Scholar
• Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169–180.
   PubMed Web of Science ®Google Scholar
• EuroQoul-Group. Electronic citation. <http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/User_Guide_v2_March_2009.pdf>. Last accessed 25 April 2009.
   Google Scholar
• Rudolph T, Farbu E. Hospital-referred polyneuropathies-causes, prevalences, clinical- and neurophysiological findings. Eur J Neurol 2007;14:603–608.
   PubMed Web of Science ®Google Scholar
• Jann S, Sandro Beretta Manuela Bramerio Carlo Alberto Defanti. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001;24:1197–1201.
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS, Proteggente A, Swan AV. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127:1723–1730.
   PubMed Web of Science ®Google Scholar